What are the recommended treatments for seborrheic dermatitis?

Treatment of Seborrheic Dermatitis

For seborrheic dermatitis, start with topical antifungal agents (ketoconazole or ciclopirox) combined with low-potency topical corticosteroids for initial flare control, then transition to maintenance therapy with antifungals alone or calcineurin inhibitors to prevent relapse. 1, 2

Scalp Seborrheic Dermatitis

First-Line Treatment

• Begin with over-the-counter antifungal shampoos containing ketoconazole, selenium sulfide, or zinc pyrithione applied 2-3 times weekly 1
• For prescription-strength treatment, use antifungal solutions, foams, or oils (ketoconazole 2%) 1
• Add low-potency corticosteroid solutions or foams (hydrocortisone or desonide) applied once or twice daily for 2-4 weeks during active flares 1, 3

Thick Scale Management

• Apply keratolytic shampoos and lotions containing salicylic acid to loosen thick, adherent scales before antifungal treatment 1
• In neonates with cradle cap, use mineral oil to loosen scale followed by gentle combing; most cases self-resolve by 6 months 1

Facial and Body Seborrheic Dermatitis

Acute Flare Management

• Apply low-potency topical corticosteroids (hydrocortisone 1-2.5% or desonide) to facial areas twice daily for 2-4 weeks maximum 1, 3, 2
• Combine with topical antifungal creams (ketoconazole 2% or ciclopirox 1%) applied once or twice daily 1, 2
• Avoid medium- or high-potency corticosteroids on facial skin due to atrophy risk and higher absorption 4

Maintenance and Steroid-Sparing Options

• Transition to calcineurin inhibitors (pimecrolimus 1% or tacrolimus 0.03-0.1%) applied 2-3 times weekly to previously affected areas after corticosteroid taper 1, 5, 2
• Pimecrolimus demonstrates the lowest recurrence rates and highest clearance rates for facial seborrheic dermatitis 2
• Lithium succinate or gluconate (8% gel) applied twice daily is highly effective, achieving total clearance more often than azoles (RR 1.79) 3, 2

Emerging Non-Steroidal Options

• Roflumilast 0.3% foam (topical phosphodiesterase-4 inhibitor) shows promise as a non-corticosteroid alternative for moderate disease 5

Comparative Efficacy Evidence

Steroids vs. Antifungals

• Topical steroids and azoles show comparable total clearance rates (RR 1.11,95% CI 0.94-1.32), but steroids reduce erythema and scaling more effectively in short-term use 3
• Mild (class I-II) and strong (class III-IV) steroids demonstrate similar efficacy for short-term treatment, but mild steroids achieve better long-term clearance (RR 0.79) 3

Calcineurin Inhibitors vs. Steroids

• No significant difference in total clearance between steroids and calcineurin inhibitors (RR 1.08,95% CI 0.88-1.32), but steroids cause fewer adverse events (RR 0.22) 3
• Calcineurin inhibitors are preferred for long-term maintenance due to absence of skin atrophy risk 2

Treatment Algorithm

1. Initial 2-4 weeks: Low-potency corticosteroid + antifungal (ketoconazole or ciclopirox) twice daily
2. Weeks 4-8: Taper corticosteroid while continuing antifungal, introduce calcineurin inhibitor 2-3 times weekly
3. Maintenance: Antifungal 2-3 times weekly OR calcineurin inhibitor 2-3 times weekly to prevent relapse 1, 5, 2

What NOT to Do

• Do not use potent or very potent corticosteroids on facial skin except for extremely limited periods due to atrophy and telangiectasia risk 4
• Do not prescribe topical antihistamines, as they provide no benefit for seborrheic dermatitis 4
• Do not use systemic corticosteroids for localized disease; reserve only for severe, refractory cases 4
• Avoid topical antimicrobial agents unless secondary bacterial infection is clinically evident with crusting or weeping 4

Severe or Refractory Disease

• Reserve systemic therapies (oral antifungals, isotretinoin, or immunomodulators) for severe cases unresponsive to topical treatment 5
• Consider referral to dermatology when non-dermatologists fail to achieve clearance, as specialists achieve optimal initial management in 96.4% vs. 73.3% of cases 6